Skip to content

Exercise is Medicine: a Pilot Study

Exercise is Medicine for Chronic Diseases: a Pilot Study for Future Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03922022
Enrollment
30
Registered
2019-04-19
Start date
2019-05-21
Completion date
2019-12-01
Last updated
2019-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Hypertension

Brief summary

Background: Regular exercise is beneficial to patients with hypertension and/or diabetes mellitus. However, most patients cannot maintain exercise habit. The investigators had developed a program called the exercise is medicine(EIM), combining motivational technique, information technology use and teaching exercise techniques. Before using this intervention in a main randomized controlled trial, the investigators would like to test its feasibility and acceptability. It is hypothesized that this program is feasible and acceptable to patients. Method: 40 patients with HT and/or DM will be recruited to attend the EIM intervention. Primary outcomes will be the rate of recruitment and rate of retention. Other clinical outcomes will be obtained before and immediately after the 12-week program.

Interventions

BEHAVIORALEIM exercise classes and intervention

This is a complex intervention. On recruitment, they will be seen by a nurse and counselled using motivational technique. They will then undergo a 12-week class. The exercise levels will be regularly feedback to the patients by use of mobile devices and trackers. Peer support is formed during the 12-week class. Resources to continue exercise will be provided to patients. Regular monitoring of physical improvement will be feedback to patients to encourage continued exercise.

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

patients will go to different classes: (i) Hypertension basic exercise class (ii) Hypertension advanced exercise class (iii) diabetes basic exercise class (iv) diabetes advanced exercise class; if the patient has normal BMI AND reported some regular exercise, they will be prescribed the advanced level class. There is no control group for this pilot study

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* clinic systolic BP(SBP) higher than 130mmHg (for HT class) because the Hong Kong primary care office guideline, as of Jan 2019, regarded good control of SBP to be ≤130mmHg, OR HbA1c \>7% (for DM class) * self-reported regular exercise of ≤3 times per week - this cut-off is arbitrary but people who exercise more than 3 times may have little space for improvement; and these patients will unlikely be referred to EIM when it is implemented in routine clinical practice, - who have used any mobile apps on their phone (because the intervention involve use of apps to monitor and remind regular exercise)

Exclusion criteria

* patients with diagnosed chronic obstructive lung disease and recent stroke (within last 12 months) are excluded because there are other evidence-proven and well-structured programmes for these patients in the Hospital Authority (HA), for instance, pulmonary rehabilitation program conducted by physiotherapy and/or occupational therapist in HA. - - acute myocardial infarction in last 6 months * ongoing angina * uncontrolled cardiac arrhythmia * acute diseases including known active endocarditis/acute pulmonary embolism, pulmonary infarction, deep vein thrombosis, acute aortic dissection, acute myocarditis * known aortic stenosis * known heart failure * known obstructive left main coronary artery stenosis * uncontrolled ventricular rates * complete heart block * known hypertrophic obstructive cardiomyopathy * mental impairment that limit co-operation * resting blood pressure with systolic blood pressure \>180mmHg or diastolic blood pressure \>110mmHg * known anaemia with haemoglobin level less than 11gm/dL * known uncorrected electrolyte imbalance * known uncontrolled hyperthyroidism. * For DM patients, patients with proliferative diabetic retinopathy and recent retinal bleeding (in last 12 months) are also excluded due to reports that vigorous exercise may increase blood pressure and led to retinal bleeding in these patients

Design outcomes

Primary

MeasureTime frameDescription
rate of retentionfrom recruitment to finish of the 12-week programrate of retention
Rate of recruitmentfrom recruitment to the start of the 12-week programRate of recruitment

Secondary

MeasureTime frameDescription
Godin-Shephard Laiesure-Time Physical Activity Questoinnaireon recruitment and after the 12- week classa validated questionnaire to detect change in exercise level
body mass index (BMI)on recruitment and after the 12- week classthe weight and height of the patients will be measured
body fat percentageon recruitment and after the 12- week classbody fat percentage
Clinic blood pressure (BP)on recruitment and after the 12- week classClinical BP will be measured 3 times and the last 2 will be averaged
9-item patient health questionnaireon recruitment and after the 12- week classa validated questionnaire to detect depressive symptoms
Generalized anxiety disorder-7on recruitment and after the 12- week classa validated questionnaire to detect anxiety symptoms
EQ-5D-5Lon recruitment and after the 12- week classa validated questionnaire to measure quality of life
lipid levelon recruitment and after the 12- week classthis will include low-density lipoprotein, high-density lipoprotein, and total lipoprotein
HbA1c (glycosylated hemoglobin)on recruitment and after the 12- week classfor DM patients only

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026